Does RhumbLine Advisers own AXSM stock?

Yes. As of its Q2 2026 13F, RhumbLine Advisers holds 44,815 shares of AXSM (Axsome Therapeutics), worth $11M.

How many shares of AXSM does RhumbLine Advisers own?

As of its Q2 2026 13F, RhumbLine Advisers holds 44,815 shares of AXSM (Axsome Therapeutics).

As of its Q2 2026 13F, RhumbLine Advisers' AXSM position is worth $11M.

In Q2 2026, RhumbLine Advisers reduced its AXSM position by 6,804 shares (-13.2%).

RhumbLine Advisers first reported AXSM in its Q2 2019 13F and has listed it in 29 quarterly 13F filings.

29 quarters

Position history for RhumbLine Advisers's holdings in Axsome Therapeutics, Inc.

Current Value

$11M

Current Shares

44,815

Total Value Change

+$10.2M

Total Shares Change

+13,541

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	44,815	-13.2%	$11M	0.0%	$244.77	0
2026-Q1	Decreased	51,619	-1.2%	$8.7M	0.0%	$169.02	0
2025-Q4	Decreased	52,233	-14.1%	$9.5M	0.0%	$182.64	0
2025-Q3	Decreased	60,778	-1.7%	$7.4M	0.0%	$121.45	0
2025-Q2	Increased	61,807	+12.9%	$6.5M	0.0%	$104.39	31
2025-Q1	Increased	54,760	+6.9%	$6.4M	0.0%	$116.63	29
2024-Q4	Decreased	51,245	-0.3%	$4.3M	0.0%	$84.61	0
2024-Q3	Decreased	51,393	-6.4%	$4.6M	0.0%	$89.87	0
2024-Q2	Increased	54,931	+5.1%	$4.4M	0.0%	$80.50	28
2024-Q1	Increased	52,257	+3.2%	$4.2M	0.0%	$79.80	28
2023-Q4	Decreased	50,637	-0.4%	$4M	0.0%	$79.59	0
2023-Q3	Increased	50,845	+8.8%	$3.6M	0.0%	$69.89	29
2023-Q2	Increased	46,710	+6.0%	$3.4M	0.0%	$71.86	28
2023-Q1	Increased	44,077	+2.6%	$2.7M	0.0%	$61.68	27
2022-Q4	Increased	42,939	+10.5%	$3.3M	0.0%	$77.13	29
2022-Q3	Increased	38,856	+12.7%	$1.7M	0.0%	$44.62	29
2022-Q2	Increased	34,484	+17.2%	$1.3M	0.0%	$38.30	30
2022-Q1	Decreased	29,421	-0.6%	$1.2M	0.0%	$41.39	0
2021-Q4	Decreased	29,586	-1.1%	$1.1M	0.0%	$37.78	0
2021-Q3	Increased	29,930	+1.2%	$986,000	0.0%	$32.96	25
2021-Q2	Decreased	29,564	-3.8%	$2M	0.0%	$67.46	0
2021-Q1	Decreased	30,732	-13.9%	$1.7M	0.0%	$56.62	0
2020-Q4	Increased	35,700	+3.0%	$2.9M	0.0%	$81.47	27
2020-Q3	Decreased	34,659	-21.1%	$2.5M	0.0%	$71.25	0
2020-Q2	Increased	43,919	+15.5%	$3.6M	0.0%	$82.28	31
2020-Q1	Increased	38,031	+10.0%	$2.2M	0.0%	$58.83	29
2019-Q4	Increased	34,576	+8.7%	$3.6M	0.0%	$103.36	29
2019-Q3	Increased	31,799	+1.7%	$644,000	0.0%	$20.24	25
2019-Q2	New	31,274	-	$805,000	0.0%	$25.75	34